Industry Impact Weighed As US Supreme Court Refuses Skinny-Label Review

Teva Vows To Fight On With ‘Additional Defenses’ As Case Returns To District Court

 
• By Dave Wallace
  
Supreme Court long shot
The Supreme Court has declined to rehear the GSK-Teva litigation

More from Legal & IP

More from Generics Bulletin